Get started
Author

Rebekka Krumbach

Observed name: R. Krumbach
OpenAlex ID: A5020203684
Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: Activation of MET as one mechanism for drug resistance
2011 · Rebekka Krumbach, Julia Schüler, et al. · European Journal of Cancer · 141
Signal processing by its coil zipper domain activates IKKγ
2008 · Stuart Bloor, Grigor Ryzhakov, et al. · Proceedings of the National Academy of Sciences · 61
Endoplasmic reticulum chaperone gp96 is essential for infection with vesicular stomatitis virus
2010 · Stuart Bloor, Jonathan Maelfait, et al. · Proceedings of the National Academy of Sciences · 58
Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones
2011 · Thomas Beckers, Andreas Sellmer, et al. · Bioorganic & Medicinal Chemistry · 29
Somatic Cell Genetics for the Study of NF-κB Signaling in Innate ImmunityA presentation from the EMBO Meeting “Cellular Signaling & Molecular Medicine,” Cavtat, Croatia, 29 March to 6 April 2008.
2008 · Rebekka Krumbach, Stuart Bloor, et al. · Science Signaling · 5
Abstract C25: The use of a patient derived tumor xenograft collection to assess different Met and HGF detection methods and their predictive values for therapy response.
2013 · Vincent Vuaroqueaux, Torsten Giesemann, et al. · Molecular Cancer Therapeutics · 1
Abstract B178: A functional mutational profile of a compendium of 350 patient-derived tumor xenografts (PDXs).
2013 · Rebekka Krumbach, Jagatheswari Virajah, et al. · Molecular Cancer Therapeutics · 1
Abstract 2774: The molecular determinants of sensitivity to HER2 targeted therapy in Patient Derived Xenograft gastric tumor models from Caucasian and Eastern Asian patients.
2013 · Vincent Vuaroqueaux, Andreas Ackermann, et al. · Cancer Research · 1
Abstract 4170: Mutation and chemosensitivity profiling of 18 human melanoma cell lines
2012 · Gerhard Kelter, Rebekka Krumbach, et al. · Cancer Research · 1
Abstract A52: PTEN/PTENP1 transcripts expression and alterations in a large panel of human tumor xenograft in nude mice: Implication for resistance to targeted therapies involving EGFR/PI3K/PTEN pathways.
2011 · Vincent Vuaroqueaux, Andreas Ackermann, et al. · Molecular Cancer Therapeutics · 1
Abstract A231: Combination of MET and EGFR inhibitors in patient-derived tumor xenografts.
2011 · Rebekka Krumbach, Armin Maier, et al. · Molecular Cancer Therapeutics · 1
Abstract 3528: In vitro profiling of kinase inhibitors and targeted anticancer agents in panels of patient-derived xenografts using a clonogenic assay
2011 · Armin Maier, Thomas Metz, et al. · Cancer Research · 1
634 Patient-derived breast cancer xenografts: Molecular characteristics and growth properties
2010 · T. Giesemann, R. Krumbach, et al. · European Journal of Cancer Supplements · 1
Abstract 3282: Molecular characterization of a panel of patient-derived breast cancer xenografts
2010 · Torsten Giesemann, Rebekka Krumbach, et al. · Cancer Research · 1
Abstract 209: Laser capture microdissection of metastatic colon adenocarcinoma samples enables RNA sequencing analysis of tumor and stromal compartments
2018 · Stephanie Littlewood, Rebekka Krumbach, et al. · Cancer Research
Abstract C8: Functional and molecular characteristics of patient-derived xenografts of colon cancer.
2013 · Jianing M. Guo, Kerstin Klingner, et al. · Molecular Cancer Therapeutics
Abstract C30: A KRAS pathway activation index predicting response to MEK inhibitors in patient-derived tumor xenografts.
2013 · Anne-Lise Peille, Armin Maier, et al. · Molecular Cancer Therapeutics
Abstract B111: Molecular and chemosensitivity profiling of melanoma cell lines with acquired resistance to BRAF inhibitor Vemurafenib.
2013 · Rebekka Krumbach, Anne-Lise Peille, et al. · Molecular Cancer Therapeutics
Abstract 3835: Ex vivo 3D assay: rapid and reliable replication of the in vivo anti-tumor efficacy of c-Met inhibitors.
2013 · Sabine Gorynia, Jianing Guo, et al. · Cancer Research
Abstract 3381: Overcoming resistance to BRAF inhibitors in colon cancer and melanoma cell lines.
2013 · Gerhard Kelter, Rebekka Krumbach, et al. · Cancer Research
Abstract 817: Genomic evolution landscape of patient tumor derived xenograft of gastric cancer.
2013 · Kun Yu, Swee Seong Wong, et al. · Cancer Research
Abstract 2789: Functional and molecular characteristics of 20 novel patient-derived xenografts of Asian gastric cancer.
2013 · Rebekka Krumbach, Seong-Ho Kong, et al. · Cancer Research
470 Identification of Patient-derived Tumor Xenografts Carrying Amplified Receptor Tyrosine Kinase Genes: Implications for Target-directed Therapies
2012 · A. Ackermann, J. Virayah, et al. · European Journal of Cancer
339 Activities of Rapalog mTOR Inhibitors Everolimus and Temsirolimus in Patient-derived Tumors Engrafted in Nude Mice: Association with Molecular Determinants
2012 · V. Vuaroqueaux, A. Maier, et al. · European Journal of Cancer
161 Investigation of Resistance to BRAF Inhibitors in Colon Cancer: Mutation and Chemosensitivity Profiling of 20 Human Colon Cancer Cell Lines
2012 · G. Kelter, R. Krumbach, et al. · European Journal of Cancer
Works count: 32
Citation count: 303
H-index: 5
I10-index: 4
Year
Topic
Type